Biomedical Engineering Reference
In-Depth Information
Table 1
(continued)
Reference
Subjects
Primary outcomes
Studies included
Major results: effect size (95% CI)
LS BMD (g/cm 2 ):
Exercisers
[ 41 ]
Premenopausal women
LS, FN BMD
3 CTs (individual data)
0.006 ± 0.035
Controls
0.008 ± 0.091
FN BMD (g/cm 2 ):
Exercisers
0.005 ± 0.031
Controls
0.003 ± 0.031
No significant effects
FN BMD (g/cm 2 ):
[ 42 ]
Postmenopausal women
FN BMD
5 RCTs
5 CTs (individual data)
Exercisers
0.004 ± 0.039
Controls
0.001 ± 0.048
No significant effects
[ 53 ]
Postmenopausal women and elderly men
Any BMD
5 RCTs
No significant effects
2 CTs (tai chi studies)
[ 61 ]
Postmenopausal women
LS, FN, total hip BMD
15 RCTs (RT studies)
LS BMD
0.006 (0.002-0.011)
FN BMD
0.010 (-0.002-0.021)
Hip BMD
0.002 (-0.001-0.005)
[ 62 ]
Premenopausal women
LS, FN BMD
6 RCTs, 1 CT (RT studies)
LS BMD
0.014 (0.009-0.019)
FN BMD
0.001 (-0.006-0.008)
[ 58 ]
Postmenopausal women
LS, FN BMD
5 RCTs, 3 CTs (walking studies)
LS BMD
0.007 (-0.001-0.016)
FN BMD
0.014 (0.000-0.028)
[ 59 ]
Postmenopausal women
LS, FN, total hip BMD
10 RCTs
LS BMD
0.015 (0.005-0.025)
5 CT (impact exercise)
FN BMD
0.008 (0.004-0.013)
Hip BMD
0.013 (0.001-0.024)
[ 60 ]
Premenopausal women
LS, FN BMD
6 RCTs, 3 CTs (impact exercise)
LS BMD
0.006 (0.002-0.010)
FN BMD
0.012 (0.005-0.020)
(continued)
Search WWH ::




Custom Search